Early globus pallidus internus stimulation in pediatric patients with generalized primary dystonia: long-term

Jan Hinnerk Mehrkens1, Ingo Borggraefe, Berend Feddersen

  • 1Department of Neurosurgery, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany. Jan.Mehrkens@med.uni-muenchen.de.

Insights

Deep brain stimulation of the globus pallidus internus effectively treats pediatric primary generalized dystonia, significantly improving motor function. Early surgical intervention is key to preventing long-term motor impairment.

Area of Science:

  • Neurology
  • Neurosurgery
  • Pediatric Neurology

Background:

  • Primary generalized dystonia is a severe, disabling condition often presenting in youth.
  • Current treatment options for pediatric dystonia are limited, necessitating advanced therapeutic approaches.

Purpose of the Study:

  • To evaluate the long-term efficacy and safety of globus pallidus internus deep brain stimulation (GPi DBS) in pediatric patients with primary generalized dystonia.

Main Methods:

  • A retrospective analysis of 5 pediatric patients with primary generalized dystonia who underwent GPi DBS.
  • Long-term follow-up (mean 73 months) assessing motor function using the Burke-Fahn-Marsden (BFM) movement score.

Main Results:

  • Significant mean improvement in BFM scores: 67.4% at 3 months, 75.4% at 12 months, and 83.5% long-term (>36 months).
  • Two patients experienced hardware complications (electrode dislocation/cable issues) requiring revision surgery without lasting sequelae.
  • Mild dysarthria was observed in two patients; no other significant therapy-related morbidity was reported.

Conclusions:

  • Globus pallidus internus deep brain stimulation is a highly effective and safe treatment for pediatric primary generalized dystonia.
  • Early neurosurgical intervention with GPi DBS is critical for optimizing outcomes and preventing irreversible motor deficits.

Related Concept Videos

Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison01:09

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...